Pharmacology Studies and Animal Model Development and Related Services for Drug Development
Award Notice Posted
- Solicitation number
- 75N95023R00004-AwardNotice1
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Awarded
- to Lovelace Biomedical Research Institute
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N95024D00027 Federal IDV award
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Health and Human Services National Institutes of Health (NIH) awarded contract 75N95024D00027 to LOVELACE BIOMEDICAL RESEARCH INSTITUTE on August 6, 2024 for $48,882,666.00. The contract is for pharmacology studies, animal model development, and related services to support drug development. No set-aside was used for this federal contract opportunity.
Notice text
Awarded contract 75N95024D00027 to LOVELACE BIOMEDICAL RESEARCH INSTITUTE for 48882666.00 on 2024-08-06.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Pharmacology Studies and Animal Model Development and Related Services for Drug Development | Award Notice | |
| This notice | Award Notice | |
| Pharmacology Studies and Animal Model Development and Related Services for Drug Development | Solicitation | |
| Pharmacology Studies and Animal Model Development and Related Services for Drug Development | Pre-Solicitation | |
| Pharmacology Studies and Animal Model Development and Related Services for Drug Development | Pre-Solicitation | |
| Pharmacology Studies and Animal Model Development and Related Services for Drug Development | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Pre-Clinical Models of Infectious Diseases | National Institute of Allergy and Infectious Diseases | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity